{"gene":"RGS12","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1998,"finding":"RGS12 acts as a GTPase-activating protein (GAP) selectively for Gi class alpha subunits in vitro, and its N-terminal PDZ domain binds selectively to C-terminal (A/S)-T-X-(L/V) motifs found in CXCR2 and an alternatively spliced form of RGS12 itself, providing a mechanism for targeting specific GPCRs for desensitization.","method":"In vitro GTPase assay; biochemical and interaction trap (yeast two-hybrid) experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical GAP assay plus orthogonal interaction trap for PDZ binding, single lab but two independent methods","pmids":["9651375"],"is_preprint":false},{"year":2001,"finding":"The C-terminal GoLoco motif of RGS12 binds exclusively to GDP-bound Gαi1, Gαi2, and Gαi3 and acts as a guanine nucleotide dissociation inhibitor (GDI), inhibiting GDP→GTP exchange and stabilizing Gαi1 in its GDP-bound form, independent of the N-terminal RGS box GAP activity.","method":"In vitro GTPγS binding assay; intrinsic tryptophan fluorescence assay; AlF4⁻-stimulated conformational change assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal in vitro biochemical assays (GTPγS binding, tryptophan fluorescence, AlF4⁻ assay) in a single rigorous study, replicated across both RGS12 and RGS14","pmids":["11387333"],"is_preprint":false},{"year":2000,"finding":"RGS12 is recruited to the N-type (Cav2.2) calcium channel in DRG neurons via its PTB domain upon agonist-induced tyrosine kinase activation downstream of GABA-B receptor, forming an endogenous complex that alters the time course of voltage-independent inhibition of calcium current; the PDZ and RGS domains of RGS12 had no observable effect on this process.","method":"Co-immunoprecipitation from primary DRG neuron lysates; microinjection of domain-specific fusion proteins with electrophysiological recording","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP from endogenous neuronal tissue combined with electrophysiology-based domain-deletion functional assay, replicated in follow-up work","pmids":["11130074"],"is_preprint":false},{"year":2000,"finding":"Alternatively spliced RGS12 isoforms with distinct N-termini localize exclusively to the nucleus in COS-7 cells; the trans-spliced short isoform (RGS12TS-S) concentrates in discrete nuclear foci in a cell-cycle-dependent manner, associates with metaphase chromosomes during mitosis, and its ectopic expression induces abnormally shaped and multiple nuclei.","method":"Confocal microscopy; subcellular fractionation; live-cell imaging across cell cycle stages","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by confocal and fractionation with cell-cycle functional consequence, single lab","pmids":["10869340"],"is_preprint":false},{"year":2004,"finding":"The PTB domain of RGS12 binds to the SNARE-binding (synprint) region (amino acids 726–985) of the Cav2.2 alpha1 subunit in a tyrosine-phosphorylation-dependent manner at Tyr-804 (not Tyr-815), as mapped by protein overlay, surface plasmon resonance, and peptide precipitation assays; microinjection of synprint peptides containing phospho-Tyr-804 altered the desensitization rate of GABA-mediated channel inhibition.","method":"Protein overlay assay; surface plasmon resonance; peptide pulldown from DRG lysates; electrophysiology (microinjection of peptides)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biochemical methods (SPR, overlay, pulldown) plus functional electrophysiological validation, single lab","pmids":["15536086"],"is_preprint":false},{"year":2007,"finding":"RGS12 associates with TrkA, activated H-Ras, B-Raf, and MEK2, acting as a scaffold to facilitate coordinated signaling to prolonged ERK activation; siRNA-mediated knockdown of RGS12 inhibits NGF-mediated neurite outgrowth of PC12 cells and axonal growth of primary DRG neurons, but not bFGF-stimulated outgrowth.","method":"Co-immunoprecipitation; siRNA knockdown with neurite outgrowth assay in PC12 cells and primary DRG neurons","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP for complex assembly plus siRNA loss-of-function with receptor-selective phenotypic readout, two cell systems","pmids":["17380122"],"is_preprint":false},{"year":2007,"finding":"RGS12 is required for RANKL-induced [Ca²⁺]i oscillations, PLCγ phosphorylation, NFAT2 expression, and terminal osteoclast differentiation; RGS12 directly interacts with N-type calcium channels in osteoclast-like cells stimulated by RANKL.","method":"Lentivirus/vector-based RNAi gene silencing; co-immunoprecipitation; calcium imaging; immunoblotting","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with multiple downstream readouts plus direct Co-IP interaction, single lab","pmids":["17042716"],"is_preprint":false},{"year":2005,"finding":"The PDZ/PTB N-terminal domain and PTB domain of RGS12 can form a complex with the PDGFβ receptor, and overexpression of these domains reduces PDGF-induced p42/p44 MAPK activation; RGS12 co-localizes with PDGFβ receptor in cytoplasmic vesicles in airway smooth muscle cells.","method":"Co-immunoprecipitation; overexpression/domain-deletion functional assays measuring ERK activation; confocal co-localization","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional domain overexpression plus co-localization, single lab, multiple methods","pmids":["16214305"],"is_preprint":false},{"year":2013,"finding":"Conditional deletion of Rgs12 in Mx1+ hematopoietic (monocyte/macrophage) cells using inducible Mx1-Cre reduces osteoclast numbers and increases bone mass in vivo, establishing an in vivo requirement for RGS12 in osteoclastogenesis with no significant effect on osteoblast formation.","method":"Conditional knockout (Mx1-Cre; Rgs12fl/fl) mouse model; microCT; histomorphometry","journal":"Genesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo conditional knockout with defined cellular and skeletal phenotype, single lab","pmids":["23349096"],"is_preprint":false},{"year":2014,"finding":"Gβγ-dependent activation of PI3Kγ and cSrc leads to tyrosine phosphorylation of Gαi1/2/3, which recruits RGS12 (via its PTB domain) to form a Gαi–RGS12 complex that accelerates Gαi deactivation and facilitates smooth muscle relaxation; tyrosine-deficient Gαi2 mutants and RGS12 knockdown each blocked phosphorylation and Gαi2–RGS12 association, causing augmented Gαi signaling.","method":"Co-immunoprecipitation; expression of tyrosine-deficient Gαi2 mutants; RGS12 siRNA knockdown; cAMP assay; smooth muscle contraction assay","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis of substrate (Gαi2 Y→F), RNAi loss-of-function, Co-IP, and functional cAMP/contractility readout, multiple orthogonal approaches in a single study","pmids":["24578342"],"is_preprint":false},{"year":2017,"finding":"RGS12 exhibits tumor-suppressor activity in prostate cancer by decreasing total and activated AKT levels and negatively regulating MNX1 expression in vitro and in vivo; RGS12 expression negatively correlates with MNX1 and AKT activity in a functionally validated manner.","method":"Knockdown/overexpression in prostate cancer cell lines; in vivo xenograft; immunoblotting for AKT and MNX1","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss- and gain-of-function in vitro plus in vivo xenograft, AKT/MNX1 mechanistic readout, single lab","pmids":["28611045"],"is_preprint":false},{"year":2019,"finding":"RGS12 associates with NF-κB(p65) via its PTB domain to activate p65 phosphorylation and nuclear translocation in macrophages; NF-κB(p65) in turn transcriptionally regulates RGS12 expression; COX2 enhances nuclear translocation of both proteins. Deletion of RGS12 in myeloid lineage inhibits collagen-induced arthritis.","method":"Co-immunoprecipitation; domain-deletion mapping; NF-κB reporter assay; conditional knockout mouse model; siRNA knockdown in vivo/in vitro","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping, reporter assay for NF-κB activity, conditional KO in vivo, single lab","pmids":["32512384"],"is_preprint":false},{"year":2019,"finding":"Rgs12 conditional knockout in osteoblast precursors (Osx-Cre) reduces osteoblast number and bone mass in vivo. Mechanistically, Rgs12 deletion inhibits GTPase activity, reduces cAMP levels, impairs L-type Ca²⁺ channel–mediated Ca²⁺ oscillations, and suppresses ERK phosphorylation; pertussis toxin (PTX) treatment or Rgs12 overexpression rescues ERK activity and osteoblast differentiation, placing Rgs12 in a Gαi-ERK axis during osteogenesis.","method":"Conditional knockout (OsxCre; Rgs12fl/fl); GTPase activity assay; cAMP assay; Ca²⁺ imaging; PTX inhibitor rescue; ERK immunoblotting; in vitro differentiation assay","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vivo conditional KO with multiple orthogonal biochemical and cell biological mechanistic assays plus pharmacological rescue, single lab","pmids":["30489658"],"is_preprint":false},{"year":2019,"finding":"RGS12 forms a protein complex with KOR (kappa opioid receptor) in ventral striatal tissue and transfected cells; RGS12-null mice show increased KOR levels and G protein activation in the ventral striatum, enhanced sensitivity to KOR agonist-induced G protein-dependent behaviors (hypolocomotion, analgesia), but attenuated KOR-mediated conditioned place aversion (β-arrestin-dependent). RGS12 simultaneously attenuates G protein signaling and augments β-arrestin signaling downstream of KOR.","method":"Co-immunoprecipitation; fast-scan cyclic voltammetry; RGS12-null mouse behavioral studies; [35S]GTPγS binding for G protein activation; ventral striatum-selective phenotyping","journal":"Neuropsychopharmacology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing complex, multiple in vivo behavioral assays with genetic null mice, biochemical G protein activation assay, multiple orthogonal methods single lab","pmids":["31141817"],"is_preprint":false},{"year":2019,"finding":"RGS12 is expressed in myoblasts and its protein abundance decreases during differentiation into myotubes; myoblasts from Rgs12-null mice have impaired ability to differentiate into myotubes ex vivo, and Pax7-Cre conditional knockout mice show attenuated muscle fiber repair after cardiotoxin injury.","method":"Conditional knockout mouse (Pax7-Cre; Rgs12fl/fl); ex vivo myoblast differentiation assay; cardiotoxin injury/regeneration model","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo conditional KO plus ex vivo differentiation assay, defined phenotypic readout, single lab","pmids":["31408461"],"is_preprint":false},{"year":2020,"finding":"RGS12 is present in mitochondria of primary chondrocytes and cartilage tissues; deletion of Rgs12 in type II collagen-positive chondrocytes decreases mitochondrial number, membrane potential, and oxidative phosphorylation. Mechanistically, RGS12 promotes tyrosine phosphorylation of ATP5A (ATP synthase subunit), enhancing its function; Rgs12-deficient mice exhibit body retardation, decreased bone mass, and chondrocyte apoptosis.","method":"Subcellular fractionation/mitochondrial localization; conditional knockout (Col2a1-Cre; Rgs12fl/fl); mitochondrial functional assays (membrane potential, OXPHOS); Co-IP/immunoblotting for ATP5A phosphorylation","journal":"Cell discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization by fractionation, in vivo conditional KO, biochemical mechanism (ATP5A phosphorylation), single lab","pmids":["32922858"],"is_preprint":false},{"year":2020,"finding":"RGS12 associates with PTEN via its PDZ domain, upregulating PTEN phosphorylation and SUMOylation, which inactivates AKT/mTOR signaling; knockout of RGS12 in mice promotes aggressive oral squamous cell carcinoma in a 4NQO model, and RGS12 knockdown in OSCC cells increases proliferation and migration.","method":"Co-immunoprecipitation (PDZ domain); knockout mouse model (CMVCre; Rgs12fl/fl) with 4NQO-induced OSCC; knockdown/overexpression in cancer cell lines; immunoblotting for pPTEN, SUMOylated PTEN, pAKT, pmTOR; in vivo xenograft","journal":"Journal of dental research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing PDZ–PTEN complex, in vivo KO model, loss/gain-of-function, multiple downstream readouts, single lab","pmids":["33198557"],"is_preprint":false},{"year":2020,"finding":"Genetic deletion of Rgs12 in mice causes brain region-specific alterations in serotonin transporter (SERT) expression and function, with no hyperlocomotion to MDMA; RGS12-null mice show increased anxiety-like and anti-depressive-like behaviors, establishing RGS12 as a modulator of serotonergic neurotransmission.","method":"Rgs12 global knockout mice; open-field and home-cage locomotor assays; SERT expression by immunoblotting; SERT functional uptake assays; behavioral assays (FST, TST, EPM, EZM, social interaction)","journal":"Journal of psychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo null mouse with biochemical SERT assay and multiple behavioral readouts, single lab","pmids":["32842837"],"is_preprint":false},{"year":2021,"finding":"RGS12 knockdown in osteosarcoma cells upregulates Ezrin expression through promoting the GNA12/13–RhoA–YAP pathway; RGS12 negatively regulates YAP/TEAD1 transcriptional activity through its PDZ domain, suppressing Ezrin expression; PDZ domain peptides of RGS12 inhibit intratibial tumor growth and lung metastasis in orthotopic xenograft models.","method":"siRNA knockdown; orthotopic xenograft mouse model; luciferase reporter for YAP/TEAD1 activity; PDZ domain peptide treatment; immunoblotting for GNA12/13, RhoA, YAP, Ezrin","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with pathway epistasis, in vivo model, reporter assay, PDZ domain functional validation, single lab","pmids":["33686240"],"is_preprint":false},{"year":2021,"finding":"RGS12 promotes ubiquitination and proteasomal degradation of IκB in macrophages, thereby activating NF-κB nuclear translocation and cytokine expression; RGS12 also indirectly suppresses MTAP expression (which would otherwise promote pIκB), and RGS12 deficiency prevents IκB ubiquitination and inflammation in surgically or chemically induced osteoarthritis.","method":"Co-immunoprecipitation (ubiquitin–IκB association); MG132 proteasome inhibitor rescue; RGS12 KO in OA model; immunoblotting for IκB, pIκB, MTAP, NF-κB","journal":"Genes & diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of ubiquitin complex, pharmacological rescue, in vivo KO model, single lab","pmids":["35873013"],"is_preprint":false},{"year":2021,"finding":"RGS12 overexpression in macrophages promotes M1 polarization (not M2) and enhances migration; RGS12 associates with and activates MYCBP2, which targets KIF2A for degradation to promote ciliogenesis in tumor-associated macrophages, and RGS12 KO in macrophages decreases M1 TAMs in oral cancer tissue.","method":"Macrophage-specific RGS12 knockout mouse; co-immunoprecipitation; overexpression in macrophages; cilia imaging; immunoblotting for MYCBP2, KIF2A; cytokine measurements","journal":"International journal of oral science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing MYCBP2 interaction, in vivo macrophage-specific KO, cilia functional readout, single lab","pmids":["36797232"],"is_preprint":false},{"year":2022,"finding":"RGS12 is required to polarize the GPSM2–GNAI complex to the hair cell apical membrane and to organize mechanosensory stereocilia into rows of graded heights; Rgs12 mouse mutants are deaf. RGS12 and GPSM2 share GoLoco motifs that stabilize GNAI(GDP), with GPSM2 outcompeting RGS12 for GNAI binding; RGS12 and the GEF DAPLE are asymmetrically co-enriched at hair cell apical junctions, suggesting that polarized GEF/GAP activity generates free GNAI(GDP) for GPSM2.","method":"Rgs12 mouse mutant (knockout); confocal immunofluorescence for GPSM2, GNAI, RGS12, DAPLE; scanning electron microscopy of stereocilia; auditory brainstem response (deafness phenotype); competitive binding analysis","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic mutant with stereocilia/hearing phenotype, direct protein localization, competitive binding mechanism, multiple orthogonal methods","pmids":["36260679"],"is_preprint":false},{"year":2022,"finding":"RGS12 in endothelial cells promotes ciliogenesis (increased cilia number and length) by associating with MYCBP2 and enhancing its phosphorylation; IFT80 knockout blocks the cilia increase caused by RGS12 overexpression; RGS12 KO reduces angiogenesis and inflammatory arthritis development in vivo.","method":"LC-MS/immunoprecipitation for MYCBP2 interaction; RGS12 overexpression/knockout in endothelial cells; IFT80 knockout; cilia imaging; tube formation assay; in vivo arthritis model","journal":"Cell insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — LC-MS-identified interaction confirmed by IP, functional domain KO rescue, in vivo KO model, single lab","pmids":["37193553"],"is_preprint":false},{"year":2024,"finding":"The RGS12 PDZ domain binds the C-terminus of SAPAP3 (validated by molecular docking, SPR, and co-immunoprecipitation); the familial bipolar disorder-associated R59Q missense variant significantly reduces PDZ domain binding affinity for three peptide targets tested by SPR, likely through allosteric changes that weaken ligand interactions.","method":"Surface plasmon resonance; co-immunoprecipitation; molecular docking; AlphaFold2 structural modeling; molecular dynamics simulation","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — SPR for quantitative binding, Co-IP, molecular modeling; variant functional characterization; single lab","pmids":["39518985"],"is_preprint":false},{"year":2024,"finding":"RGS12 C-terminal PDZ ligand binds NHERF1; full-length RGS12 and its upstream PDZ-domain-containing fragment bind NPT2A; the downstream RGS12 portion (without PDZ domain) does not interact with NPT2A but contains the inhibitory activity for hormone-sensitive phosphate transport comparable to RGS14.","method":"Immunoblotting co-pulldown for NHERF1; structural fragment binding analysis for NPT2A; phosphate uptake assay in opossum kidney proximal tubule cells with RGS12/RGS14 transfection","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assays with domain mapping plus functional transport assay, single lab","pmids":["39293332"],"is_preprint":false},{"year":2024,"finding":"DLGAP3 forms a complex with RGS12 (by co-immunoprecipitation); DLGAP3 overexpression increases RGS12 expression and RGS12 inhibits BRAF transcription and translation, reducing MEK/ERK phosphorylation in glioma cells.","method":"Co-immunoprecipitation; overexpression/knockdown in glioma cells; immunoblotting for pMEK, pERK, BRAF; dual-luciferase reporter for BRAF transcription","journal":"Brain research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP plus reporter assay, single lab, no direct RGS12 loss-of-function in this mechanism","pmids":["39551229"],"is_preprint":false},{"year":2025,"finding":"In female (but not male) DRG nociceptor-specific Rgs12-cKO mice, pain sensitivity to mechanical and thermal stimuli is decreased, neurite outgrowth is reduced, and GPER expression dramatically increases; GPER-mediated Ca²⁺ signaling in DRG neurons is sex-dependent, placing RGS12 upstream of estrogen/GPER–calcium signaling in female nociceptors.","method":"Conditional knockout (Trpv1-Cre; Rgs12fl/fl); von Frey, hot plate, and CPP behavioral assays; Ca²⁺ imaging in primary DRG neurons; immunofluorescence; qRT-PCR and immunoblotting for GPER","journal":"The journal of pain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — sex-specific conditional KO with multiple behavioral and cellular readouts, Ca²⁺ imaging, molecular pathway analysis; single lab","pmids":["41352678"],"is_preprint":false},{"year":2026,"finding":"RGS12 localizes to the mitochondria of placental trophoblast cells and promotes tyrosine phosphorylation of ATP5B (mitochondrial ATP synthase subunit); RGS12 knockdown reduces mitochondrial abundance, impairs oxidative phosphorylation, and decreases antioxidant capacity; placental Rgs12 deficiency in mice leads to preterm birth susceptibility, reduced fetal weight, and trophoblast apoptosis linked to p38MAPK activation.","method":"Subcellular fractionation/mitochondrial localization; siRNA knockdown in placental cells; conditional knockout mouse; Co-IP/immunoblotting for ATP5B tyrosine phosphorylation; mitochondrial functional assays; p38MAPK immunoblotting","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization, Co-IP with phosphorylation readout, in vivo mouse model; single lab","pmids":["41663754"],"is_preprint":false}],"current_model":"RGS12 is a multi-domain scaffold protein that (1) accelerates GTP hydrolysis on Gαi/o subunits via its RGS-box GAP activity, (2) stabilizes GDP-bound Gαi via its GoLoco motif GDI activity, (3) binds tyrosine-phosphorylated effectors (e.g., Cav2.2 synprint region at pTyr-804, Gαi subunits phosphorylated by cSrc) through its PTB domain to regulate signal termination kinetics, (4) scaffolds activated Ras/B-Raf/MEK2 complexes for NGF-TrkA→ERK signaling required for neuronal differentiation, (5) polarizes the GPSM2–GNAI(GDP) complex in sensory hair cells to organize stereocilia and enable hearing, (6) drives osteoclastogenesis and osteoblastogenesis via PLCγ/Ca²⁺/NFAT2 and Gαi-ERK pathways respectively, (7) activates NF-κB(p65) via PTB-domain-mediated interaction and enhances IκB ubiquitination/degradation in macrophages, (8) regulates KOR-dependent dopaminergic and serotonergic neurotransmission in the ventral striatum, and (9) maintains mitochondrial function in chondrocytes and trophoblasts by promoting tyrosine phosphorylation of ATP synthase subunits."},"narrative":{"mechanistic_narrative":"RGS12 is a large multi-domain scaffold protein that integrates heterotrimeric G-protein regulation with receptor tyrosine kinase and MAPK signaling across diverse cell types [PMID:9651375, PMID:17380122]. Its catalytic RGS box acts as a GTPase-activating protein selective for Gi-class Gα subunits, while a separate C-terminal GoLoco motif binds GDP-bound Gαi1/2/3 and functions as a guanine-nucleotide dissociation inhibitor, giving RGS12 dual, opposing control over the Gαi nucleotide cycle [PMID:9651375, PMID:11387333]. The protein also carries protein-interaction modules — an N-terminal PDZ domain and a PTB domain — that target it to specific partners: the PDZ domain recognizes C-terminal motifs of GPCRs such as CXCR2 [PMID:9651375], and the PTB domain binds tyrosine-phosphorylated effectors, including the Cav2.2 synprint region at phospho-Tyr-804 to set the kinetics of voltage-independent calcium-channel inhibition in DRG neurons [PMID:11130074, PMID:15536086] and cSrc-phosphorylated Gαi to accelerate its deactivation [PMID:24578342]. Through its PTB domain RGS12 assembles activated Ras/B-Raf/MEK2 with TrkA to sustain ERK activation required for NGF-driven neurite outgrowth [PMID:17380122]. In skeletal and immune tissues RGS12 drives osteoclast differentiation via RANKL-induced PLCγ/Ca²⁺/NFAT2 signaling and osteoblast differentiation via a Gαi–ERK axis [PMID:17042716, PMID:30489658], and it activates NF-κB by promoting IκB ubiquitination and p65 nuclear translocation in macrophages [PMID:32512384, PMID:35873013]. RGS12 is essential for hearing, where it polarizes the GPSM2–GNAI(GDP) complex to organize stereocilia [PMID:36260679], and it supports mitochondrial oxidative phosphorylation in chondrocytes and trophoblasts by promoting tyrosine phosphorylation of ATP synthase subunits [PMID:32922858, PMID:41663754]. The PDZ domain further engages PTEN, NHERF1/NPT2A, and YAP/TEAD signaling, and its disruption by a bipolar-disorder-associated R59Q variant weakens ligand binding [PMID:33198557, PMID:39518985, PMID:39293332, PMID:33686240].","teleology":[{"year":1998,"claim":"Established RGS12's core biochemical identity — a Gi-selective GAP whose PDZ domain targets specific GPCRs — defining it as a receptor-coupled signal-termination scaffold rather than a simple GAP.","evidence":"In vitro GTPase assay and yeast two-hybrid/biochemical PDZ-binding mapping","pmids":["9651375"],"confidence":"High","gaps":["Cellular context of CXCR2 desensitization not tested in vivo","Whether PDZ targeting couples GAP activity to receptor not resolved biochemically"]},{"year":2000,"claim":"Showed that distinct RGS12 isoforms localize to the nucleus and associate with mitotic chromosomes, raising a cell-cycle/nuclear role separate from G-protein signaling.","evidence":"Confocal microscopy, subcellular fractionation, and live-cell imaging in COS-7 cells","pmids":["10869340"],"confidence":"Medium","gaps":["Nuclear molecular function unidentified","No partners defined for the nuclear isoform","Link between nuclear localization and abnormal nuclei mechanistically unexplained"]},{"year":2000,"claim":"Demonstrated that the PTB domain, not PDZ or RGS domains, recruits RGS12 to the N-type calcium channel to tune voltage-independent inhibition, defining a domain-specific effector-coupling mechanism in neurons.","evidence":"Co-IP from endogenous DRG neurons plus domain-specific fusion-protein microinjection with electrophysiology","pmids":["11130074"],"confidence":"High","gaps":["Identity of the activating tyrosine kinase not established","Direct channel-binding site not yet mapped"]},{"year":2001,"claim":"Resolved that RGS12 has a second, independent G-protein activity — a GoLoco-motif GDI that stabilizes GDP-bound Gαi — making RGS12 bifunctional within a single polypeptide.","evidence":"In vitro GTPγS binding, intrinsic tryptophan fluorescence, and AlF4⁻ conformational assays","pmids":["11387333"],"confidence":"High","gaps":["How GAP and GDI activities are coordinated in cells unclear","No structural picture of full-length domain arrangement"]},{"year":2004,"claim":"Mapped the PTB–channel interaction to phospho-Tyr-804 of the Cav2.2 synprint region, mechanistically grounding phosphorylation-dependent recruitment in signal-termination kinetics.","evidence":"Protein overlay, surface plasmon resonance, peptide pulldown, and phospho-peptide microinjection electrophysiology","pmids":["15536086"],"confidence":"High","gaps":["Kinase responsible for Tyr-804 phosphorylation not identified","Stoichiometry within native channel complex unknown"]},{"year":2005,"claim":"Extended RGS12 scaffolding to receptor tyrosine kinases by showing its PDZ/PTB region binds the PDGFβ receptor and dampens MAPK activation, indicating broad RTK regulatory capacity.","evidence":"Co-IP, domain-overexpression ERK assays, and confocal co-localization in airway smooth muscle cells","pmids":["16214305"],"confidence":"Medium","gaps":["Endogenous loss-of-function not tested","Phospho-dependence of PDGFβR binding not mapped"]},{"year":2007,"claim":"Defined RGS12 as a positive ERK scaffold downstream of TrkA, assembling Ras/B-Raf/MEK2 to drive NGF-specific neurite/axon outgrowth — a function opposite to its RTK-dampening role.","evidence":"Co-IP for complex assembly plus siRNA knockdown with receptor-selective outgrowth assays in PC12 and DRG neurons","pmids":["17380122"],"confidence":"High","gaps":["Which RGS12 domain anchors each MAPK-cascade component not fully resolved","Reconciliation with negative PDGF regulation not addressed"]},{"year":2007,"claim":"Connected RGS12 to bone remodeling by showing it is required for RANKL-induced Ca²⁺ oscillations, PLCγ/NFAT2 signaling, and osteoclast differentiation.","evidence":"RNAi silencing, Co-IP with N-type channels, calcium imaging, and immunoblotting in osteoclast-like cells","pmids":["17042716"],"confidence":"Medium","gaps":["In vivo requirement not yet established at this stage","Direct molecular link between RGS12 and PLCγ unmapped"]},{"year":2013,"claim":"Provided in vivo proof that RGS12 is required in monocyte/macrophage lineage for osteoclastogenesis and bone-mass control.","evidence":"Mx1-Cre conditional knockout mouse with microCT and histomorphometry","pmids":["23349096"],"confidence":"Medium","gaps":["Molecular effectors in vivo not dissected","Osteoblast-autonomous role not addressed here"]},{"year":2014,"claim":"Showed RGS12 PTB binding to cSrc-tyrosine-phosphorylated Gαi accelerates Gαi deactivation, integrating PTB-effector recognition with the GAP function in smooth muscle physiology.","evidence":"Co-IP, Gαi2 Tyr→Phe mutants, siRNA knockdown, cAMP, and contractility assays","pmids":["24578342"],"confidence":"High","gaps":["Structural basis of PTB–phospho-Gαi recognition not resolved","Generality across Gαi isoforms in vivo untested"]},{"year":2017,"claim":"Identified a tumor-suppressor role in prostate cancer via repression of MNX1 and AKT activity, broadening RGS12 function to growth control.","evidence":"Knockdown/overexpression in cell lines and xenografts with AKT/MNX1 immunoblotting","pmids":["28611045"],"confidence":"Medium","gaps":["Mechanism linking RGS12 domains to MNX1/AKT undefined","Direct binding partners in this axis not identified"]},{"year":2019,"claim":"Established that RGS12 PTB drives NF-κB(p65) activation in a feed-forward loop and is required for inflammatory arthritis, linking the scaffold to innate immune transcription.","evidence":"Co-IP, domain mapping, NF-κB reporter, myeloid conditional KO, and siRNA","pmids":["32512384"],"confidence":"Medium","gaps":["Direct p65 vs IκB target of PTB binding not fully separated","Role of COX2 enhancement mechanistically incomplete"]},{"year":2019,"claim":"Demonstrated osteoblast-autonomous RGS12 function through a Gαi-ERK axis, placing GTPase, cAMP, and L-type Ca²⁺ signaling within bone formation.","evidence":"Osx-Cre conditional KO with GTPase, cAMP, Ca²⁺ imaging, PTX rescue, and ERK assays","pmids":["30489658"],"confidence":"High","gaps":["How RGS12 couples to L-type channels mechanistically unclear","Relationship to its osteoclast role in same animal not integrated"]},{"year":2019,"claim":"Showed RGS12 forms a KOR complex that biases opioid signaling — attenuating G protein output while augmenting β-arrestin output — modulating striatal neurotransmission and behavior.","evidence":"Co-IP, [35S]GTPγS binding, fast-scan cyclic voltammetry, and RGS12-null behavioral phenotyping","pmids":["31141817"],"confidence":"High","gaps":["Domain mediating KOR binding not mapped","Mechanism of β-arrestin augmentation unknown"]},{"year":2019,"claim":"Extended RGS12's developmental roles to skeletal muscle by showing it is required for myoblast differentiation and injury repair.","evidence":"Pax7-Cre conditional KO with ex vivo differentiation and cardiotoxin regeneration model","pmids":["31408461"],"confidence":"Medium","gaps":["Molecular signaling pathway in myoblasts undefined","Domain requirement untested"]},{"year":2020,"claim":"Revealed an unexpected mitochondrial role: RGS12 localizes to chondrocyte mitochondria and promotes ATP5A tyrosine phosphorylation to sustain oxidative phosphorylation and prevent apoptosis.","evidence":"Mitochondrial fractionation, Col2a1-Cre conditional KO, OXPHOS/membrane potential assays, and ATP5A phospho-immunoblotting","pmids":["32922858"],"confidence":"Medium","gaps":["Whether RGS12 directly mediates phosphorylation or recruits a kinase unknown","How a G-protein scaffold reaches the mitochondrial matrix unexplained"]},{"year":2020,"claim":"Linked RGS12 to serotonergic neurotransmission by showing null mice have altered SERT and affective behaviors.","evidence":"Global Rgs12 KO with SERT uptake/immunoblotting and behavioral battery","pmids":["32842837"],"confidence":"Medium","gaps":["Direct molecular interaction with SERT or upstream receptors not shown","Region-specific cell type not defined"]},{"year":2020,"claim":"Identified a PDZ-mediated RGS12–PTEN interaction that enhances PTEN phospho/SUMOylation and suppresses AKT/mTOR, providing a tumor-suppressor mechanism in oral squamous cell carcinoma.","evidence":"PDZ Co-IP, CMV-Cre KO with 4NQO OSCC model, knockdown/overexpression, and pathway immunoblotting","pmids":["33198557"],"confidence":"Medium","gaps":["Whether PDZ binds PTEN directly or via adaptor unresolved","Reconciliation with growth-promoting roles elsewhere not addressed"]},{"year":2021,"claim":"Detailed how RGS12 drives IκB ubiquitination/degradation and NF-κB activation to promote osteoarthritis inflammation, deepening its pro-inflammatory mechanism.","evidence":"Ubiquitin–IκB Co-IP, MG132 rescue, RGS12 KO OA model, and immunoblotting","pmids":["35873013"],"confidence":"Medium","gaps":["E3 ligase recruited by RGS12 not identified","Direct vs indirect MTAP regulation unclear"]},{"year":2021,"claim":"Showed RGS12 negatively regulates GNA12/13–RhoA–YAP/TEAD signaling through its PDZ domain to suppress osteosarcoma growth and metastasis, and that PDZ peptides are therapeutically active.","evidence":"siRNA, orthotopic xenograft, YAP/TEAD reporter, PDZ peptide treatment, and pathway immunoblotting","pmids":["33686240"],"confidence":"Medium","gaps":["Direct PDZ ligand within the GNA12/13–YAP axis not identified","Selectivity of PDZ peptide effects unclear"]},{"year":2022,"claim":"Defined RGS12's essential role in hearing: it polarizes GPSM2–GNAI(GDP) to organize stereocilia, with RGS12 and GPSM2 sharing GoLoco competition and RGS12/DAPLE generating polarized GEF/GAP activity.","evidence":"Rgs12 mutant mice with deafness phenotype, immunofluorescence, scanning EM, ABR, and competitive binding","pmids":["36260679"],"confidence":"High","gaps":["Quantitative balance of RGS12 GAP vs GDI at the apical membrane not resolved","Whether RGS box or GoLoco dominates in vivo unclear"]},{"year":2022,"claim":"Connected RGS12 to ciliogenesis and angiogenesis by showing it associates with MYCBP2 and requires IFT80 to promote endothelial cilia, with KO reducing angiogenesis and arthritis.","evidence":"LC-MS/IP for MYCBP2, overexpression/KO in endothelial cells, IFT80 KO, cilia imaging, tube formation, and in vivo arthritis model","pmids":["37193553"],"confidence":"Medium","gaps":["How RGS12 enhances MYCBP2 phosphorylation unclear","Domain mediating MYCBP2 binding not mapped"]},{"year":2023,"claim":"Showed RGS12 promotes macrophage M1 polarization and ciliogenesis via MYCBP2–KIF2A in tumor-associated macrophages, integrating its cilia and immune functions.","evidence":"Macrophage-specific KO, Co-IP, overexpression, cilia imaging, and cytokine measurements","pmids":["36797232"],"confidence":"Medium","gaps":["Direct enzymatic link between RGS12 and MYCBP2 activation unknown","Relationship to NF-κB-driven polarization unintegrated"]},{"year":2024,"claim":"Characterized PDZ-domain ligand specificity (SAPAP3) and showed a bipolar-disorder-associated R59Q variant weakens PDZ binding, linking RGS12 to a neuropsychiatric disease allele.","evidence":"SPR, Co-IP, molecular docking, AlphaFold2, and molecular dynamics","pmids":["39518985"],"confidence":"Medium","gaps":["Cellular consequence of R59Q not tested","Causality in disease not established by family/rescue data"]},{"year":2024,"claim":"Extended PDZ-domain partnerships to renal phosphate handling, with RGS12 binding NHERF1/NPT2A and harboring transport-inhibitory activity comparable to RGS14.","evidence":"Co-pulldown, domain-fragment binding analysis, and phosphate uptake assay in opossum kidney cells","pmids":["39293332"],"confidence":"Medium","gaps":["In vivo renal phosphate role untested","Domain responsible for inhibitory activity only coarsely localized"]},{"year":2025,"claim":"Revealed a sex-dependent role in female nociceptors, where RGS12 loss reduces pain sensitivity and neurite outgrowth and upregulates GPER–Ca²⁺ signaling.","evidence":"Trpv1-Cre conditional KO, behavioral pain assays, DRG Ca²⁺ imaging, and GPER expression analysis","pmids":["41352678"],"confidence":"Medium","gaps":["Mechanism of sex specificity unexplained","Direct RGS12–GPER molecular relationship not shown"]},{"year":2026,"claim":"Generalized the mitochondrial mechanism to placenta, where RGS12 promotes ATP5B tyrosine phosphorylation to maintain OXPHOS and prevent trophoblast apoptosis, with deficiency causing preterm birth susceptibility.","evidence":"Mitochondrial fractionation, siRNA, conditional KO mouse, ATP5B phospho Co-IP, OXPHOS assays, and p38MAPK immunoblotting","pmids":["41663754"],"confidence":"Medium","gaps":["Kinase mediating ATP5B phosphorylation unidentified","Mechanism of mitochondrial targeting unresolved"]},{"year":null,"claim":"It remains unresolved how RGS12's multiple, biochemically opposing activities (GAP, GDI, PDZ/PTB scaffolding, mitochondrial phospho-regulation) are selected and coordinated within a single cell, and no full-length structural model integrates its domains.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of full-length RGS12 or its multi-domain complexes","Rules governing GAP-vs-GDI and positive-vs-negative ERK scaffolding unknown","Mechanism of mitochondrial localization and ATP synthase phosphorylation undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,9]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,4,5]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[15,27]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[11,18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,4,21]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[15,27]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,9,13]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,12,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[11,19,20]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,16,18]}],"complexes":[],"partners":["GNAI2","CACNA1B","TRKA","GPSM2","MYCBP2","PTEN","NHERF1","OPRK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O14924","full_name":"Regulator of G-protein signaling 12","aliases":[],"length_aa":1447,"mass_kda":156.4,"function":"Regulates G protein-coupled receptor signaling cascades. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form Behaves as a cell cycle-dependent transcriptional repressor, promoting inhibition of S-phase DNA synthesis","subcellular_location":"Nucleus matrix","url":"https://www.uniprot.org/uniprotkb/O14924/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RGS12","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RGS12","total_profiled":1310},"omim":[{"mim_id":"612027","title":"TRAFFICKING REGULATOR AND SCAFFOLD PROTEIN TAMALIN; TAMALIN","url":"https://www.omim.org/entry/612027"},{"mim_id":"602513","title":"REGULATOR OF G PROTEIN SIGNALING 14; RGS14","url":"https://www.omim.org/entry/602513"},{"mim_id":"602512","title":"REGULATOR OF G PROTEIN SIGNALING 12; RGS12","url":"https://www.omim.org/entry/602512"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RGS12"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O14924","domains":[{"cath_id":"2.30.42.10","chopping":"21-97","consensus_level":"high","plddt":87.0305,"start":21,"end":97},{"cath_id":"2.30.29.30","chopping":"229-320_335-409","consensus_level":"high","plddt":75.447,"start":229,"end":409},{"cath_id":"1.10.167.10","chopping":"709-838","consensus_level":"high","plddt":89.8316,"start":709,"end":838},{"cath_id":"3.10.20.90","chopping":"963-1032","consensus_level":"medium","plddt":86.8663,"start":963,"end":1032},{"cath_id":"3.10.20.90","chopping":"1034-1105","consensus_level":"medium","plddt":88.7621,"start":1034,"end":1105}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O14924","model_url":"https://alphafold.ebi.ac.uk/files/AF-O14924-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O14924-F1-predicted_aligned_error_v6.png","plddt_mean":53.72},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RGS12","jax_strain_url":"https://www.jax.org/strain/search?query=RGS12"},"sequence":{"accession":"O14924","fasta_url":"https://rest.uniprot.org/uniprotkb/O14924.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O14924/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O14924"}},"corpus_meta":[{"pmid":"11387333","id":"PMC_11387333","title":"RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction sites with guanine nucleotide dissociation inhibitor Activity.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11387333","citation_count":193,"is_preprint":false},{"pmid":"9651375","id":"PMC_9651375","title":"GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9651375","citation_count":186,"is_preprint":false},{"pmid":"11130074","id":"PMC_11130074","title":"Tyrosine-kinase-dependent recruitment of RGS12 to the N-type calcium channel.","date":"2000","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11130074","citation_count":119,"is_preprint":false},{"pmid":"9168931","id":"PMC_9168931","title":"Molecular cloning and expression analysis of rat Rgs12 and Rgs14.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9168931","citation_count":108,"is_preprint":false},{"pmid":"17380122","id":"PMC_17380122","title":"Selective role for RGS12 as a Ras/Raf/MEK scaffold in nerve growth factor-mediated differentiation.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17380122","citation_count":68,"is_preprint":false},{"pmid":"10869340","id":"PMC_10869340","title":"Novel alternative splicing and nuclear localization of human RGS12 gene products.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10869340","citation_count":61,"is_preprint":false},{"pmid":"17042716","id":"PMC_17042716","title":"RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro.","date":"2007","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/17042716","citation_count":53,"is_preprint":false},{"pmid":"10606204","id":"PMC_10606204","title":"Raf-like Ras/Rap-binding domains in RGS12- and still-life-like signalling proteins.","date":"1999","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/10606204","citation_count":52,"is_preprint":false},{"pmid":"15536086","id":"PMC_15536086","title":"RGS12 interacts with the SNARE-binding region of the Cav2.2 calcium channel.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15536086","citation_count":38,"is_preprint":false},{"pmid":"34674723","id":"PMC_34674723","title":"MicroRNA-204-5p reduction in rat hippocampus contributes to stress-induced pathology via targeting RGS12 signaling pathway.","date":"2021","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/34674723","citation_count":37,"is_preprint":false},{"pmid":"16214305","id":"PMC_16214305","title":"The effect of RGS12 on PDGFbeta receptor signalling to p42/p44 mitogen activated protein kinase in mammalian cells.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/16214305","citation_count":35,"is_preprint":false},{"pmid":"28611045","id":"PMC_28611045","title":"RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28611045","citation_count":31,"is_preprint":false},{"pmid":"33686240","id":"PMC_33686240","title":"RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33686240","citation_count":25,"is_preprint":false},{"pmid":"33198557","id":"PMC_33198557","title":"RGS12 Represses Oral Cancer via the Phosphorylation and SUMOylation of PTEN.","date":"2020","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/33198557","citation_count":24,"is_preprint":false},{"pmid":"30489658","id":"PMC_30489658","title":"Regulator of G Protein Signaling Protein 12 (Rgs12) Controls Mouse Osteoblast Differentiation via Calcium Channel/Oscillation and Gαi-ERK Signaling.","date":"2019","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/30489658","citation_count":24,"is_preprint":false},{"pmid":"23349096","id":"PMC_23349096","title":"Mx1-cre mediated Rgs12 conditional knockout mice exhibit increased bone mass phenotype.","date":"2013","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/23349096","citation_count":21,"is_preprint":false},{"pmid":"36797232","id":"PMC_36797232","title":"RGS12 represses oral squamous cell carcinoma by driving M1 polarization of tumor-associated macrophages via controlling ciliary MYCBP2/KIF2A signaling.","date":"2023","source":"International journal of oral science","url":"https://pubmed.ncbi.nlm.nih.gov/36797232","citation_count":19,"is_preprint":false},{"pmid":"31141817","id":"PMC_31141817","title":"Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.","date":"2019","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31141817","citation_count":19,"is_preprint":false},{"pmid":"34796776","id":"PMC_34796776","title":"RGS12 Drives Macrophage Activation and Osteoclastogenesis in Periodontitis.","date":"2021","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/34796776","citation_count":18,"is_preprint":false},{"pmid":"32512384","id":"PMC_32512384","title":"RGS12 Is a Novel Critical NF-κB Activator in Inflammatory Arthritis.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32512384","citation_count":18,"is_preprint":false},{"pmid":"35873013","id":"PMC_35873013","title":"Macrophage RGS12 contributes to osteoarthritis pathogenesis through enhancing the ubiquitination.","date":"2021","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35873013","citation_count":15,"is_preprint":false},{"pmid":"24578342","id":"PMC_24578342","title":"Inhibition of Gαi activity by Gβγ is mediated by PI 3-kinase-γ- and cSrc-dependent tyrosine phosphorylation of Gαi and recruitment of RGS12.","date":"2014","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24578342","citation_count":13,"is_preprint":false},{"pmid":"31408461","id":"PMC_31408461","title":"A role for Regulator of G protein Signaling-12 (RGS12) in the balance between myoblast proliferation and differentiation.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31408461","citation_count":12,"is_preprint":false},{"pmid":"32922858","id":"PMC_32922858","title":"RGS12 is required for the maintenance of mitochondrial function during skeletal development.","date":"2020","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/32922858","citation_count":12,"is_preprint":false},{"pmid":"15488181","id":"PMC_15488181","title":"Mapping of RGS12-Cav2.2 channel interaction.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488181","citation_count":11,"is_preprint":false},{"pmid":"36260679","id":"PMC_36260679","title":"RGS12 polarizes the GPSM2-GNAI complex to organize and elongate stereocilia in sensory hair cells.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36260679","citation_count":10,"is_preprint":false},{"pmid":"15488192","id":"PMC_15488192","title":"Purification and in vitro functional analyses of RGS12 and RGS14 GoLoco motif peptides.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488192","citation_count":9,"is_preprint":false},{"pmid":"32842837","id":"PMC_32842837","title":"Genetic deletion of Rgs12 in mice affects serotonin transporter expression and function in vivo and ex vivo.","date":"2020","source":"Journal of psychopharmacology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32842837","citation_count":7,"is_preprint":false},{"pmid":"37193553","id":"PMC_37193553","title":"Endothelial RGS12 governs angiogenesis in inflammatory arthritis by controlling cilia formation and elongation via MYCBP2 signaling.","date":"2022","source":"Cell insight","url":"https://pubmed.ncbi.nlm.nih.gov/37193553","citation_count":6,"is_preprint":false},{"pmid":"39293332","id":"PMC_39293332","title":"Distinct and overlapping RGS14 and RGS12 actions regulate NPT2A-mediated phosphate transport.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/39293332","citation_count":3,"is_preprint":false},{"pmid":"39930821","id":"PMC_39930821","title":"RGS12 is a target of penehyclidine hydrochloride that enhances oxidative stress and ferroptosis in a model of myocardial ischemia/reperfusion injury by inhibiting the Nrf2 pathway.","date":"2025","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39930821","citation_count":3,"is_preprint":false},{"pmid":"39551229","id":"PMC_39551229","title":"DLGAP3 suppresses malignant behaviors of glioma cells via inhibiting RGS12-mediated MAPK/ERK signaling.","date":"2024","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/39551229","citation_count":2,"is_preprint":false},{"pmid":"39518985","id":"PMC_39518985","title":"Molecular Modeling and In Vitro Functional Analysis of the RGS12 PDZ Domain Variant Associated with High-Penetrance Familial Bipolar Disorder.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39518985","citation_count":1,"is_preprint":false},{"pmid":"40271194","id":"PMC_40271194","title":"The role of RGS12 in tissue repair and human diseases.","date":"2024","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/40271194","citation_count":0,"is_preprint":false},{"pmid":"41352678","id":"PMC_41352678","title":"RGS12 controls pain/mechanical sensitivity in a sex-dependent manner via regulating the estrogen/GPER-calcium signaling pathway.","date":"2025","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/41352678","citation_count":0,"is_preprint":false},{"pmid":"41663754","id":"PMC_41663754","title":"Role of RGS12 in placental mitochondrial dysfunction and adverse pregnancy outcomes.","date":"2026","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/41663754","citation_count":0,"is_preprint":false},{"pmid":"41465420","id":"PMC_41465420","title":"Functional Variation in RGS12 Should Not Preclude Methylphenidate Use in Bipolar Disorder with Established Mood Stabilization: Preclinical Evidence.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41465420","citation_count":0,"is_preprint":false},{"pmid":"37965246","id":"PMC_37965246","title":"Corrigendum to \"Endothelial RGS12 governs angiogenesis in inflammatory arthritis by controlling cilia formation and elongation via MYCBP2 signaling\" [Cell Insight 1 (2022) 100055].","date":"2023","source":"Cell insight","url":"https://pubmed.ncbi.nlm.nih.gov/37965246","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20485,"output_tokens":7776,"usd":0.089048,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17327,"output_tokens":7724,"usd":0.139868,"stage2_stop_reason":"end_turn"},"total_usd":0.228916,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"RGS12 acts as a GTPase-activating protein (GAP) selectively for Gi class alpha subunits in vitro, and its N-terminal PDZ domain binds selectively to C-terminal (A/S)-T-X-(L/V) motifs found in CXCR2 and an alternatively spliced form of RGS12 itself, providing a mechanism for targeting specific GPCRs for desensitization.\",\n      \"method\": \"In vitro GTPase assay; biochemical and interaction trap (yeast two-hybrid) experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical GAP assay plus orthogonal interaction trap for PDZ binding, single lab but two independent methods\",\n      \"pmids\": [\"9651375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The C-terminal GoLoco motif of RGS12 binds exclusively to GDP-bound Gαi1, Gαi2, and Gαi3 and acts as a guanine nucleotide dissociation inhibitor (GDI), inhibiting GDP→GTP exchange and stabilizing Gαi1 in its GDP-bound form, independent of the N-terminal RGS box GAP activity.\",\n      \"method\": \"In vitro GTPγS binding assay; intrinsic tryptophan fluorescence assay; AlF4⁻-stimulated conformational change assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal in vitro biochemical assays (GTPγS binding, tryptophan fluorescence, AlF4⁻ assay) in a single rigorous study, replicated across both RGS12 and RGS14\",\n      \"pmids\": [\"11387333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS12 is recruited to the N-type (Cav2.2) calcium channel in DRG neurons via its PTB domain upon agonist-induced tyrosine kinase activation downstream of GABA-B receptor, forming an endogenous complex that alters the time course of voltage-independent inhibition of calcium current; the PDZ and RGS domains of RGS12 had no observable effect on this process.\",\n      \"method\": \"Co-immunoprecipitation from primary DRG neuron lysates; microinjection of domain-specific fusion proteins with electrophysiological recording\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP from endogenous neuronal tissue combined with electrophysiology-based domain-deletion functional assay, replicated in follow-up work\",\n      \"pmids\": [\"11130074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Alternatively spliced RGS12 isoforms with distinct N-termini localize exclusively to the nucleus in COS-7 cells; the trans-spliced short isoform (RGS12TS-S) concentrates in discrete nuclear foci in a cell-cycle-dependent manner, associates with metaphase chromosomes during mitosis, and its ectopic expression induces abnormally shaped and multiple nuclei.\",\n      \"method\": \"Confocal microscopy; subcellular fractionation; live-cell imaging across cell cycle stages\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by confocal and fractionation with cell-cycle functional consequence, single lab\",\n      \"pmids\": [\"10869340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The PTB domain of RGS12 binds to the SNARE-binding (synprint) region (amino acids 726–985) of the Cav2.2 alpha1 subunit in a tyrosine-phosphorylation-dependent manner at Tyr-804 (not Tyr-815), as mapped by protein overlay, surface plasmon resonance, and peptide precipitation assays; microinjection of synprint peptides containing phospho-Tyr-804 altered the desensitization rate of GABA-mediated channel inhibition.\",\n      \"method\": \"Protein overlay assay; surface plasmon resonance; peptide pulldown from DRG lysates; electrophysiology (microinjection of peptides)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biochemical methods (SPR, overlay, pulldown) plus functional electrophysiological validation, single lab\",\n      \"pmids\": [\"15536086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RGS12 associates with TrkA, activated H-Ras, B-Raf, and MEK2, acting as a scaffold to facilitate coordinated signaling to prolonged ERK activation; siRNA-mediated knockdown of RGS12 inhibits NGF-mediated neurite outgrowth of PC12 cells and axonal growth of primary DRG neurons, but not bFGF-stimulated outgrowth.\",\n      \"method\": \"Co-immunoprecipitation; siRNA knockdown with neurite outgrowth assay in PC12 cells and primary DRG neurons\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP for complex assembly plus siRNA loss-of-function with receptor-selective phenotypic readout, two cell systems\",\n      \"pmids\": [\"17380122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RGS12 is required for RANKL-induced [Ca²⁺]i oscillations, PLCγ phosphorylation, NFAT2 expression, and terminal osteoclast differentiation; RGS12 directly interacts with N-type calcium channels in osteoclast-like cells stimulated by RANKL.\",\n      \"method\": \"Lentivirus/vector-based RNAi gene silencing; co-immunoprecipitation; calcium imaging; immunoblotting\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with multiple downstream readouts plus direct Co-IP interaction, single lab\",\n      \"pmids\": [\"17042716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The PDZ/PTB N-terminal domain and PTB domain of RGS12 can form a complex with the PDGFβ receptor, and overexpression of these domains reduces PDGF-induced p42/p44 MAPK activation; RGS12 co-localizes with PDGFβ receptor in cytoplasmic vesicles in airway smooth muscle cells.\",\n      \"method\": \"Co-immunoprecipitation; overexpression/domain-deletion functional assays measuring ERK activation; confocal co-localization\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional domain overexpression plus co-localization, single lab, multiple methods\",\n      \"pmids\": [\"16214305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Conditional deletion of Rgs12 in Mx1+ hematopoietic (monocyte/macrophage) cells using inducible Mx1-Cre reduces osteoclast numbers and increases bone mass in vivo, establishing an in vivo requirement for RGS12 in osteoclastogenesis with no significant effect on osteoblast formation.\",\n      \"method\": \"Conditional knockout (Mx1-Cre; Rgs12fl/fl) mouse model; microCT; histomorphometry\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo conditional knockout with defined cellular and skeletal phenotype, single lab\",\n      \"pmids\": [\"23349096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Gβγ-dependent activation of PI3Kγ and cSrc leads to tyrosine phosphorylation of Gαi1/2/3, which recruits RGS12 (via its PTB domain) to form a Gαi–RGS12 complex that accelerates Gαi deactivation and facilitates smooth muscle relaxation; tyrosine-deficient Gαi2 mutants and RGS12 knockdown each blocked phosphorylation and Gαi2–RGS12 association, causing augmented Gαi signaling.\",\n      \"method\": \"Co-immunoprecipitation; expression of tyrosine-deficient Gαi2 mutants; RGS12 siRNA knockdown; cAMP assay; smooth muscle contraction assay\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis of substrate (Gαi2 Y→F), RNAi loss-of-function, Co-IP, and functional cAMP/contractility readout, multiple orthogonal approaches in a single study\",\n      \"pmids\": [\"24578342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RGS12 exhibits tumor-suppressor activity in prostate cancer by decreasing total and activated AKT levels and negatively regulating MNX1 expression in vitro and in vivo; RGS12 expression negatively correlates with MNX1 and AKT activity in a functionally validated manner.\",\n      \"method\": \"Knockdown/overexpression in prostate cancer cell lines; in vivo xenograft; immunoblotting for AKT and MNX1\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss- and gain-of-function in vitro plus in vivo xenograft, AKT/MNX1 mechanistic readout, single lab\",\n      \"pmids\": [\"28611045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RGS12 associates with NF-κB(p65) via its PTB domain to activate p65 phosphorylation and nuclear translocation in macrophages; NF-κB(p65) in turn transcriptionally regulates RGS12 expression; COX2 enhances nuclear translocation of both proteins. Deletion of RGS12 in myeloid lineage inhibits collagen-induced arthritis.\",\n      \"method\": \"Co-immunoprecipitation; domain-deletion mapping; NF-κB reporter assay; conditional knockout mouse model; siRNA knockdown in vivo/in vitro\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping, reporter assay for NF-κB activity, conditional KO in vivo, single lab\",\n      \"pmids\": [\"32512384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Rgs12 conditional knockout in osteoblast precursors (Osx-Cre) reduces osteoblast number and bone mass in vivo. Mechanistically, Rgs12 deletion inhibits GTPase activity, reduces cAMP levels, impairs L-type Ca²⁺ channel–mediated Ca²⁺ oscillations, and suppresses ERK phosphorylation; pertussis toxin (PTX) treatment or Rgs12 overexpression rescues ERK activity and osteoblast differentiation, placing Rgs12 in a Gαi-ERK axis during osteogenesis.\",\n      \"method\": \"Conditional knockout (OsxCre; Rgs12fl/fl); GTPase activity assay; cAMP assay; Ca²⁺ imaging; PTX inhibitor rescue; ERK immunoblotting; in vitro differentiation assay\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vivo conditional KO with multiple orthogonal biochemical and cell biological mechanistic assays plus pharmacological rescue, single lab\",\n      \"pmids\": [\"30489658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RGS12 forms a protein complex with KOR (kappa opioid receptor) in ventral striatal tissue and transfected cells; RGS12-null mice show increased KOR levels and G protein activation in the ventral striatum, enhanced sensitivity to KOR agonist-induced G protein-dependent behaviors (hypolocomotion, analgesia), but attenuated KOR-mediated conditioned place aversion (β-arrestin-dependent). RGS12 simultaneously attenuates G protein signaling and augments β-arrestin signaling downstream of KOR.\",\n      \"method\": \"Co-immunoprecipitation; fast-scan cyclic voltammetry; RGS12-null mouse behavioral studies; [35S]GTPγS binding for G protein activation; ventral striatum-selective phenotyping\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing complex, multiple in vivo behavioral assays with genetic null mice, biochemical G protein activation assay, multiple orthogonal methods single lab\",\n      \"pmids\": [\"31141817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RGS12 is expressed in myoblasts and its protein abundance decreases during differentiation into myotubes; myoblasts from Rgs12-null mice have impaired ability to differentiate into myotubes ex vivo, and Pax7-Cre conditional knockout mice show attenuated muscle fiber repair after cardiotoxin injury.\",\n      \"method\": \"Conditional knockout mouse (Pax7-Cre; Rgs12fl/fl); ex vivo myoblast differentiation assay; cardiotoxin injury/regeneration model\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo conditional KO plus ex vivo differentiation assay, defined phenotypic readout, single lab\",\n      \"pmids\": [\"31408461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RGS12 is present in mitochondria of primary chondrocytes and cartilage tissues; deletion of Rgs12 in type II collagen-positive chondrocytes decreases mitochondrial number, membrane potential, and oxidative phosphorylation. Mechanistically, RGS12 promotes tyrosine phosphorylation of ATP5A (ATP synthase subunit), enhancing its function; Rgs12-deficient mice exhibit body retardation, decreased bone mass, and chondrocyte apoptosis.\",\n      \"method\": \"Subcellular fractionation/mitochondrial localization; conditional knockout (Col2a1-Cre; Rgs12fl/fl); mitochondrial functional assays (membrane potential, OXPHOS); Co-IP/immunoblotting for ATP5A phosphorylation\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization by fractionation, in vivo conditional KO, biochemical mechanism (ATP5A phosphorylation), single lab\",\n      \"pmids\": [\"32922858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RGS12 associates with PTEN via its PDZ domain, upregulating PTEN phosphorylation and SUMOylation, which inactivates AKT/mTOR signaling; knockout of RGS12 in mice promotes aggressive oral squamous cell carcinoma in a 4NQO model, and RGS12 knockdown in OSCC cells increases proliferation and migration.\",\n      \"method\": \"Co-immunoprecipitation (PDZ domain); knockout mouse model (CMVCre; Rgs12fl/fl) with 4NQO-induced OSCC; knockdown/overexpression in cancer cell lines; immunoblotting for pPTEN, SUMOylated PTEN, pAKT, pmTOR; in vivo xenograft\",\n      \"journal\": \"Journal of dental research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing PDZ–PTEN complex, in vivo KO model, loss/gain-of-function, multiple downstream readouts, single lab\",\n      \"pmids\": [\"33198557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Genetic deletion of Rgs12 in mice causes brain region-specific alterations in serotonin transporter (SERT) expression and function, with no hyperlocomotion to MDMA; RGS12-null mice show increased anxiety-like and anti-depressive-like behaviors, establishing RGS12 as a modulator of serotonergic neurotransmission.\",\n      \"method\": \"Rgs12 global knockout mice; open-field and home-cage locomotor assays; SERT expression by immunoblotting; SERT functional uptake assays; behavioral assays (FST, TST, EPM, EZM, social interaction)\",\n      \"journal\": \"Journal of psychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo null mouse with biochemical SERT assay and multiple behavioral readouts, single lab\",\n      \"pmids\": [\"32842837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RGS12 knockdown in osteosarcoma cells upregulates Ezrin expression through promoting the GNA12/13–RhoA–YAP pathway; RGS12 negatively regulates YAP/TEAD1 transcriptional activity through its PDZ domain, suppressing Ezrin expression; PDZ domain peptides of RGS12 inhibit intratibial tumor growth and lung metastasis in orthotopic xenograft models.\",\n      \"method\": \"siRNA knockdown; orthotopic xenograft mouse model; luciferase reporter for YAP/TEAD1 activity; PDZ domain peptide treatment; immunoblotting for GNA12/13, RhoA, YAP, Ezrin\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with pathway epistasis, in vivo model, reporter assay, PDZ domain functional validation, single lab\",\n      \"pmids\": [\"33686240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RGS12 promotes ubiquitination and proteasomal degradation of IκB in macrophages, thereby activating NF-κB nuclear translocation and cytokine expression; RGS12 also indirectly suppresses MTAP expression (which would otherwise promote pIκB), and RGS12 deficiency prevents IκB ubiquitination and inflammation in surgically or chemically induced osteoarthritis.\",\n      \"method\": \"Co-immunoprecipitation (ubiquitin–IκB association); MG132 proteasome inhibitor rescue; RGS12 KO in OA model; immunoblotting for IκB, pIκB, MTAP, NF-κB\",\n      \"journal\": \"Genes & diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of ubiquitin complex, pharmacological rescue, in vivo KO model, single lab\",\n      \"pmids\": [\"35873013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RGS12 overexpression in macrophages promotes M1 polarization (not M2) and enhances migration; RGS12 associates with and activates MYCBP2, which targets KIF2A for degradation to promote ciliogenesis in tumor-associated macrophages, and RGS12 KO in macrophages decreases M1 TAMs in oral cancer tissue.\",\n      \"method\": \"Macrophage-specific RGS12 knockout mouse; co-immunoprecipitation; overexpression in macrophages; cilia imaging; immunoblotting for MYCBP2, KIF2A; cytokine measurements\",\n      \"journal\": \"International journal of oral science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing MYCBP2 interaction, in vivo macrophage-specific KO, cilia functional readout, single lab\",\n      \"pmids\": [\"36797232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RGS12 is required to polarize the GPSM2–GNAI complex to the hair cell apical membrane and to organize mechanosensory stereocilia into rows of graded heights; Rgs12 mouse mutants are deaf. RGS12 and GPSM2 share GoLoco motifs that stabilize GNAI(GDP), with GPSM2 outcompeting RGS12 for GNAI binding; RGS12 and the GEF DAPLE are asymmetrically co-enriched at hair cell apical junctions, suggesting that polarized GEF/GAP activity generates free GNAI(GDP) for GPSM2.\",\n      \"method\": \"Rgs12 mouse mutant (knockout); confocal immunofluorescence for GPSM2, GNAI, RGS12, DAPLE; scanning electron microscopy of stereocilia; auditory brainstem response (deafness phenotype); competitive binding analysis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic mutant with stereocilia/hearing phenotype, direct protein localization, competitive binding mechanism, multiple orthogonal methods\",\n      \"pmids\": [\"36260679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RGS12 in endothelial cells promotes ciliogenesis (increased cilia number and length) by associating with MYCBP2 and enhancing its phosphorylation; IFT80 knockout blocks the cilia increase caused by RGS12 overexpression; RGS12 KO reduces angiogenesis and inflammatory arthritis development in vivo.\",\n      \"method\": \"LC-MS/immunoprecipitation for MYCBP2 interaction; RGS12 overexpression/knockout in endothelial cells; IFT80 knockout; cilia imaging; tube formation assay; in vivo arthritis model\",\n      \"journal\": \"Cell insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — LC-MS-identified interaction confirmed by IP, functional domain KO rescue, in vivo KO model, single lab\",\n      \"pmids\": [\"37193553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The RGS12 PDZ domain binds the C-terminus of SAPAP3 (validated by molecular docking, SPR, and co-immunoprecipitation); the familial bipolar disorder-associated R59Q missense variant significantly reduces PDZ domain binding affinity for three peptide targets tested by SPR, likely through allosteric changes that weaken ligand interactions.\",\n      \"method\": \"Surface plasmon resonance; co-immunoprecipitation; molecular docking; AlphaFold2 structural modeling; molecular dynamics simulation\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — SPR for quantitative binding, Co-IP, molecular modeling; variant functional characterization; single lab\",\n      \"pmids\": [\"39518985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RGS12 C-terminal PDZ ligand binds NHERF1; full-length RGS12 and its upstream PDZ-domain-containing fragment bind NPT2A; the downstream RGS12 portion (without PDZ domain) does not interact with NPT2A but contains the inhibitory activity for hormone-sensitive phosphate transport comparable to RGS14.\",\n      \"method\": \"Immunoblotting co-pulldown for NHERF1; structural fragment binding analysis for NPT2A; phosphate uptake assay in opossum kidney proximal tubule cells with RGS12/RGS14 transfection\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assays with domain mapping plus functional transport assay, single lab\",\n      \"pmids\": [\"39293332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DLGAP3 forms a complex with RGS12 (by co-immunoprecipitation); DLGAP3 overexpression increases RGS12 expression and RGS12 inhibits BRAF transcription and translation, reducing MEK/ERK phosphorylation in glioma cells.\",\n      \"method\": \"Co-immunoprecipitation; overexpression/knockdown in glioma cells; immunoblotting for pMEK, pERK, BRAF; dual-luciferase reporter for BRAF transcription\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP plus reporter assay, single lab, no direct RGS12 loss-of-function in this mechanism\",\n      \"pmids\": [\"39551229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In female (but not male) DRG nociceptor-specific Rgs12-cKO mice, pain sensitivity to mechanical and thermal stimuli is decreased, neurite outgrowth is reduced, and GPER expression dramatically increases; GPER-mediated Ca²⁺ signaling in DRG neurons is sex-dependent, placing RGS12 upstream of estrogen/GPER–calcium signaling in female nociceptors.\",\n      \"method\": \"Conditional knockout (Trpv1-Cre; Rgs12fl/fl); von Frey, hot plate, and CPP behavioral assays; Ca²⁺ imaging in primary DRG neurons; immunofluorescence; qRT-PCR and immunoblotting for GPER\",\n      \"journal\": \"The journal of pain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — sex-specific conditional KO with multiple behavioral and cellular readouts, Ca²⁺ imaging, molecular pathway analysis; single lab\",\n      \"pmids\": [\"41352678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"RGS12 localizes to the mitochondria of placental trophoblast cells and promotes tyrosine phosphorylation of ATP5B (mitochondrial ATP synthase subunit); RGS12 knockdown reduces mitochondrial abundance, impairs oxidative phosphorylation, and decreases antioxidant capacity; placental Rgs12 deficiency in mice leads to preterm birth susceptibility, reduced fetal weight, and trophoblast apoptosis linked to p38MAPK activation.\",\n      \"method\": \"Subcellular fractionation/mitochondrial localization; siRNA knockdown in placental cells; conditional knockout mouse; Co-IP/immunoblotting for ATP5B tyrosine phosphorylation; mitochondrial functional assays; p38MAPK immunoblotting\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization, Co-IP with phosphorylation readout, in vivo mouse model; single lab\",\n      \"pmids\": [\"41663754\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RGS12 is a multi-domain scaffold protein that (1) accelerates GTP hydrolysis on Gαi/o subunits via its RGS-box GAP activity, (2) stabilizes GDP-bound Gαi via its GoLoco motif GDI activity, (3) binds tyrosine-phosphorylated effectors (e.g., Cav2.2 synprint region at pTyr-804, Gαi subunits phosphorylated by cSrc) through its PTB domain to regulate signal termination kinetics, (4) scaffolds activated Ras/B-Raf/MEK2 complexes for NGF-TrkA→ERK signaling required for neuronal differentiation, (5) polarizes the GPSM2–GNAI(GDP) complex in sensory hair cells to organize stereocilia and enable hearing, (6) drives osteoclastogenesis and osteoblastogenesis via PLCγ/Ca²⁺/NFAT2 and Gαi-ERK pathways respectively, (7) activates NF-κB(p65) via PTB-domain-mediated interaction and enhances IκB ubiquitination/degradation in macrophages, (8) regulates KOR-dependent dopaminergic and serotonergic neurotransmission in the ventral striatum, and (9) maintains mitochondrial function in chondrocytes and trophoblasts by promoting tyrosine phosphorylation of ATP synthase subunits.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RGS12 is a large multi-domain scaffold protein that integrates heterotrimeric G-protein regulation with receptor tyrosine kinase and MAPK signaling across diverse cell types [#0, #5]. Its catalytic RGS box acts as a GTPase-activating protein selective for Gi-class Gα subunits, while a separate C-terminal GoLoco motif binds GDP-bound Gαi1/2/3 and functions as a guanine-nucleotide dissociation inhibitor, giving RGS12 dual, opposing control over the Gαi nucleotide cycle [#0, #1]. The protein also carries protein-interaction modules — an N-terminal PDZ domain and a PTB domain — that target it to specific partners: the PDZ domain recognizes C-terminal motifs of GPCRs such as CXCR2 [#0], and the PTB domain binds tyrosine-phosphorylated effectors, including the Cav2.2 synprint region at phospho-Tyr-804 to set the kinetics of voltage-independent calcium-channel inhibition in DRG neurons [#2, #4] and cSrc-phosphorylated Gαi to accelerate its deactivation [#9]. Through its PTB domain RGS12 assembles activated Ras/B-Raf/MEK2 with TrkA to sustain ERK activation required for NGF-driven neurite outgrowth [#5]. In skeletal and immune tissues RGS12 drives osteoclast differentiation via RANKL-induced PLCγ/Ca²⁺/NFAT2 signaling and osteoblast differentiation via a Gαi–ERK axis [#6, #12], and it activates NF-κB by promoting IκB ubiquitination and p65 nuclear translocation in macrophages [#11, #19]. RGS12 is essential for hearing, where it polarizes the GPSM2–GNAI(GDP) complex to organize stereocilia [#21], and it supports mitochondrial oxidative phosphorylation in chondrocytes and trophoblasts by promoting tyrosine phosphorylation of ATP synthase subunits [#15, #27]. The PDZ domain further engages PTEN, NHERF1/NPT2A, and YAP/TEAD signaling, and its disruption by a bipolar-disorder-associated R59Q variant weakens ligand binding [#16, #23, #24, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established RGS12's core biochemical identity — a Gi-selective GAP whose PDZ domain targets specific GPCRs — defining it as a receptor-coupled signal-termination scaffold rather than a simple GAP.\",\n      \"evidence\": \"In vitro GTPase assay and yeast two-hybrid/biochemical PDZ-binding mapping\",\n      \"pmids\": [\"9651375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular context of CXCR2 desensitization not tested in vivo\", \"Whether PDZ targeting couples GAP activity to receptor not resolved biochemically\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showed that distinct RGS12 isoforms localize to the nucleus and associate with mitotic chromosomes, raising a cell-cycle/nuclear role separate from G-protein signaling.\",\n      \"evidence\": \"Confocal microscopy, subcellular fractionation, and live-cell imaging in COS-7 cells\",\n      \"pmids\": [\"10869340\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear molecular function unidentified\", \"No partners defined for the nuclear isoform\", \"Link between nuclear localization and abnormal nuclei mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated that the PTB domain, not PDZ or RGS domains, recruits RGS12 to the N-type calcium channel to tune voltage-independent inhibition, defining a domain-specific effector-coupling mechanism in neurons.\",\n      \"evidence\": \"Co-IP from endogenous DRG neurons plus domain-specific fusion-protein microinjection with electrophysiology\",\n      \"pmids\": [\"11130074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the activating tyrosine kinase not established\", \"Direct channel-binding site not yet mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Resolved that RGS12 has a second, independent G-protein activity — a GoLoco-motif GDI that stabilizes GDP-bound Gαi — making RGS12 bifunctional within a single polypeptide.\",\n      \"evidence\": \"In vitro GTPγS binding, intrinsic tryptophan fluorescence, and AlF4⁻ conformational assays\",\n      \"pmids\": [\"11387333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GAP and GDI activities are coordinated in cells unclear\", \"No structural picture of full-length domain arrangement\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapped the PTB–channel interaction to phospho-Tyr-804 of the Cav2.2 synprint region, mechanistically grounding phosphorylation-dependent recruitment in signal-termination kinetics.\",\n      \"evidence\": \"Protein overlay, surface plasmon resonance, peptide pulldown, and phospho-peptide microinjection electrophysiology\",\n      \"pmids\": [\"15536086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for Tyr-804 phosphorylation not identified\", \"Stoichiometry within native channel complex unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended RGS12 scaffolding to receptor tyrosine kinases by showing its PDZ/PTB region binds the PDGFβ receptor and dampens MAPK activation, indicating broad RTK regulatory capacity.\",\n      \"evidence\": \"Co-IP, domain-overexpression ERK assays, and confocal co-localization in airway smooth muscle cells\",\n      \"pmids\": [\"16214305\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous loss-of-function not tested\", \"Phospho-dependence of PDGFβR binding not mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined RGS12 as a positive ERK scaffold downstream of TrkA, assembling Ras/B-Raf/MEK2 to drive NGF-specific neurite/axon outgrowth — a function opposite to its RTK-dampening role.\",\n      \"evidence\": \"Co-IP for complex assembly plus siRNA knockdown with receptor-selective outgrowth assays in PC12 and DRG neurons\",\n      \"pmids\": [\"17380122\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which RGS12 domain anchors each MAPK-cascade component not fully resolved\", \"Reconciliation with negative PDGF regulation not addressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected RGS12 to bone remodeling by showing it is required for RANKL-induced Ca²⁺ oscillations, PLCγ/NFAT2 signaling, and osteoclast differentiation.\",\n      \"evidence\": \"RNAi silencing, Co-IP with N-type channels, calcium imaging, and immunoblotting in osteoclast-like cells\",\n      \"pmids\": [\"17042716\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo requirement not yet established at this stage\", \"Direct molecular link between RGS12 and PLCγ unmapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided in vivo proof that RGS12 is required in monocyte/macrophage lineage for osteoclastogenesis and bone-mass control.\",\n      \"evidence\": \"Mx1-Cre conditional knockout mouse with microCT and histomorphometry\",\n      \"pmids\": [\"23349096\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular effectors in vivo not dissected\", \"Osteoblast-autonomous role not addressed here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed RGS12 PTB binding to cSrc-tyrosine-phosphorylated Gαi accelerates Gαi deactivation, integrating PTB-effector recognition with the GAP function in smooth muscle physiology.\",\n      \"evidence\": \"Co-IP, Gαi2 Tyr→Phe mutants, siRNA knockdown, cAMP, and contractility assays\",\n      \"pmids\": [\"24578342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PTB–phospho-Gαi recognition not resolved\", \"Generality across Gαi isoforms in vivo untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified a tumor-suppressor role in prostate cancer via repression of MNX1 and AKT activity, broadening RGS12 function to growth control.\",\n      \"evidence\": \"Knockdown/overexpression in cell lines and xenografts with AKT/MNX1 immunoblotting\",\n      \"pmids\": [\"28611045\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking RGS12 domains to MNX1/AKT undefined\", \"Direct binding partners in this axis not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established that RGS12 PTB drives NF-κB(p65) activation in a feed-forward loop and is required for inflammatory arthritis, linking the scaffold to innate immune transcription.\",\n      \"evidence\": \"Co-IP, domain mapping, NF-κB reporter, myeloid conditional KO, and siRNA\",\n      \"pmids\": [\"32512384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct p65 vs IκB target of PTB binding not fully separated\", \"Role of COX2 enhancement mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated osteoblast-autonomous RGS12 function through a Gαi-ERK axis, placing GTPase, cAMP, and L-type Ca²⁺ signaling within bone formation.\",\n      \"evidence\": \"Osx-Cre conditional KO with GTPase, cAMP, Ca²⁺ imaging, PTX rescue, and ERK assays\",\n      \"pmids\": [\"30489658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How RGS12 couples to L-type channels mechanistically unclear\", \"Relationship to its osteoclast role in same animal not integrated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed RGS12 forms a KOR complex that biases opioid signaling — attenuating G protein output while augmenting β-arrestin output — modulating striatal neurotransmission and behavior.\",\n      \"evidence\": \"Co-IP, [35S]GTPγS binding, fast-scan cyclic voltammetry, and RGS12-null behavioral phenotyping\",\n      \"pmids\": [\"31141817\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domain mediating KOR binding not mapped\", \"Mechanism of β-arrestin augmentation unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended RGS12's developmental roles to skeletal muscle by showing it is required for myoblast differentiation and injury repair.\",\n      \"evidence\": \"Pax7-Cre conditional KO with ex vivo differentiation and cardiotoxin regeneration model\",\n      \"pmids\": [\"31408461\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular signaling pathway in myoblasts undefined\", \"Domain requirement untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed an unexpected mitochondrial role: RGS12 localizes to chondrocyte mitochondria and promotes ATP5A tyrosine phosphorylation to sustain oxidative phosphorylation and prevent apoptosis.\",\n      \"evidence\": \"Mitochondrial fractionation, Col2a1-Cre conditional KO, OXPHOS/membrane potential assays, and ATP5A phospho-immunoblotting\",\n      \"pmids\": [\"32922858\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether RGS12 directly mediates phosphorylation or recruits a kinase unknown\", \"How a G-protein scaffold reaches the mitochondrial matrix unexplained\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linked RGS12 to serotonergic neurotransmission by showing null mice have altered SERT and affective behaviors.\",\n      \"evidence\": \"Global Rgs12 KO with SERT uptake/immunoblotting and behavioral battery\",\n      \"pmids\": [\"32842837\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular interaction with SERT or upstream receptors not shown\", \"Region-specific cell type not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a PDZ-mediated RGS12–PTEN interaction that enhances PTEN phospho/SUMOylation and suppresses AKT/mTOR, providing a tumor-suppressor mechanism in oral squamous cell carcinoma.\",\n      \"evidence\": \"PDZ Co-IP, CMV-Cre KO with 4NQO OSCC model, knockdown/overexpression, and pathway immunoblotting\",\n      \"pmids\": [\"33198557\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PDZ binds PTEN directly or via adaptor unresolved\", \"Reconciliation with growth-promoting roles elsewhere not addressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Detailed how RGS12 drives IκB ubiquitination/degradation and NF-κB activation to promote osteoarthritis inflammation, deepening its pro-inflammatory mechanism.\",\n      \"evidence\": \"Ubiquitin–IκB Co-IP, MG132 rescue, RGS12 KO OA model, and immunoblotting\",\n      \"pmids\": [\"35873013\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase recruited by RGS12 not identified\", \"Direct vs indirect MTAP regulation unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed RGS12 negatively regulates GNA12/13–RhoA–YAP/TEAD signaling through its PDZ domain to suppress osteosarcoma growth and metastasis, and that PDZ peptides are therapeutically active.\",\n      \"evidence\": \"siRNA, orthotopic xenograft, YAP/TEAD reporter, PDZ peptide treatment, and pathway immunoblotting\",\n      \"pmids\": [\"33686240\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct PDZ ligand within the GNA12/13–YAP axis not identified\", \"Selectivity of PDZ peptide effects unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined RGS12's essential role in hearing: it polarizes GPSM2–GNAI(GDP) to organize stereocilia, with RGS12 and GPSM2 sharing GoLoco competition and RGS12/DAPLE generating polarized GEF/GAP activity.\",\n      \"evidence\": \"Rgs12 mutant mice with deafness phenotype, immunofluorescence, scanning EM, ABR, and competitive binding\",\n      \"pmids\": [\"36260679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative balance of RGS12 GAP vs GDI at the apical membrane not resolved\", \"Whether RGS box or GoLoco dominates in vivo unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected RGS12 to ciliogenesis and angiogenesis by showing it associates with MYCBP2 and requires IFT80 to promote endothelial cilia, with KO reducing angiogenesis and arthritis.\",\n      \"evidence\": \"LC-MS/IP for MYCBP2, overexpression/KO in endothelial cells, IFT80 KO, cilia imaging, tube formation, and in vivo arthritis model\",\n      \"pmids\": [\"37193553\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How RGS12 enhances MYCBP2 phosphorylation unclear\", \"Domain mediating MYCBP2 binding not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed RGS12 promotes macrophage M1 polarization and ciliogenesis via MYCBP2–KIF2A in tumor-associated macrophages, integrating its cilia and immune functions.\",\n      \"evidence\": \"Macrophage-specific KO, Co-IP, overexpression, cilia imaging, and cytokine measurements\",\n      \"pmids\": [\"36797232\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct enzymatic link between RGS12 and MYCBP2 activation unknown\", \"Relationship to NF-κB-driven polarization unintegrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Characterized PDZ-domain ligand specificity (SAPAP3) and showed a bipolar-disorder-associated R59Q variant weakens PDZ binding, linking RGS12 to a neuropsychiatric disease allele.\",\n      \"evidence\": \"SPR, Co-IP, molecular docking, AlphaFold2, and molecular dynamics\",\n      \"pmids\": [\"39518985\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cellular consequence of R59Q not tested\", \"Causality in disease not established by family/rescue data\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended PDZ-domain partnerships to renal phosphate handling, with RGS12 binding NHERF1/NPT2A and harboring transport-inhibitory activity comparable to RGS14.\",\n      \"evidence\": \"Co-pulldown, domain-fragment binding analysis, and phosphate uptake assay in opossum kidney cells\",\n      \"pmids\": [\"39293332\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo renal phosphate role untested\", \"Domain responsible for inhibitory activity only coarsely localized\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Revealed a sex-dependent role in female nociceptors, where RGS12 loss reduces pain sensitivity and neurite outgrowth and upregulates GPER–Ca²⁺ signaling.\",\n      \"evidence\": \"Trpv1-Cre conditional KO, behavioral pain assays, DRG Ca²⁺ imaging, and GPER expression analysis\",\n      \"pmids\": [\"41352678\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of sex specificity unexplained\", \"Direct RGS12–GPER molecular relationship not shown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Generalized the mitochondrial mechanism to placenta, where RGS12 promotes ATP5B tyrosine phosphorylation to maintain OXPHOS and prevent trophoblast apoptosis, with deficiency causing preterm birth susceptibility.\",\n      \"evidence\": \"Mitochondrial fractionation, siRNA, conditional KO mouse, ATP5B phospho Co-IP, OXPHOS assays, and p38MAPK immunoblotting\",\n      \"pmids\": [\"41663754\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase mediating ATP5B phosphorylation unidentified\", \"Mechanism of mitochondrial targeting unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how RGS12's multiple, biochemically opposing activities (GAP, GDI, PDZ/PTB scaffolding, mitochondrial phospho-regulation) are selected and coordinated within a single cell, and no full-length structural model integrates its domains.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of full-length RGS12 or its multi-domain complexes\", \"Rules governing GAP-vs-GDI and positive-vs-negative ERK scaffolding unknown\", \"Mechanism of mitochondrial localization and ATP synthase phosphorylation undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 9]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 4, 5]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [15, 27]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [11, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 4, 21]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [15, 27]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 9, 13]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 12, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [11, 19, 20]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 16, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GNAI2\", \"CACNA1B\", \"TrkA\", \"GPSM2\", \"MYCBP2\", \"PTEN\", \"NHERF1\", \"OPRK1\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}